Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan H Fox

Showing results (21-30 of 178) with videos related to

Pageof 18
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
Clinical spectrum of levodopa-induced complicationsCamila Catherine Aquino, Susan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2008
Levodopa-related motor complications--phenomenologySusan H Fox, Anthony E Lang
Current Topics in Behavioral Neurosciences|August 28, 2014
Symptomatic Models of Parkinson's Disease and L-DOPA-Induced Dyskinesia in Non-human PrimatesTom M Johnston, Susan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2014
Understanding conversion disorders: back to Freud's theoryCamila C Aquino, Susan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2018
Th17 lymphocyte spearheads the immune attack in Parkinson's disease: New evidence for neuronal deathAparna Wagle Shukla, Susan H Fox
Expert Review of Neurotherapeutics|December 15, 2012
Drug treatments for the neuropsychiatric complications of Parkinson's diseaseBarbara S Connolly, Susan H Fox
Brain : a Journal of Neurology|September 14, 2014
'Don't delay, start today': delaying levodopa does not delay motor complicationsSusan H Fox, Anthony E Lang
Expert Review of Clinical Pharmacology|October 17, 2014
New treatments for the motor symptoms of Parkinson's diseaseAnne-Catherine Vijverman, Susan H Fox
Neurodegenerative Disease Management|May 28, 2016
Nondopaminergic treatments for Parkinson's disease: current and future prospectsMaria Eliza Freitas, Susan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|December 19, 2013
New methods of preventing neurodegeneration? Lessons from prion diseasesIsabelle Beaulieu-Boire, Susan H Fox
Pageof 18

Showing results (21-30 of 178) with videos related to

Sort By:
Pageof 18
Movement Disorders : Official Journal of the Movement Disorder Society|December 10, 2014
Clinical spectrum of levodopa-induced complicationsCamila Catherine Aquino, Susan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2008
Levodopa-related motor complications--phenomenologySusan H Fox, Anthony E Lang
Current Topics in Behavioral Neurosciences|August 28, 2014
Symptomatic Models of Parkinson's Disease and L-DOPA-Induced Dyskinesia in Non-human PrimatesTom M Johnston, Susan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2014
Understanding conversion disorders: back to Freud's theoryCamila C Aquino, Susan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2018
Th17 lymphocyte spearheads the immune attack in Parkinson's disease: New evidence for neuronal deathAparna Wagle Shukla, Susan H Fox
Expert Review of Neurotherapeutics|December 15, 2012
Drug treatments for the neuropsychiatric complications of Parkinson's diseaseBarbara S Connolly, Susan H Fox
Brain : a Journal of Neurology|September 14, 2014
'Don't delay, start today': delaying levodopa does not delay motor complicationsSusan H Fox, Anthony E Lang
Expert Review of Clinical Pharmacology|October 17, 2014
New treatments for the motor symptoms of Parkinson's diseaseAnne-Catherine Vijverman, Susan H Fox
Neurodegenerative Disease Management|May 28, 2016
Nondopaminergic treatments for Parkinson's disease: current and future prospectsMaria Eliza Freitas, Susan H Fox
Movement Disorders : Official Journal of the Movement Disorder Society|December 19, 2013
New methods of preventing neurodegeneration? Lessons from prion diseasesIsabelle Beaulieu-Boire, Susan H Fox
Pageof 18